Epidemiology and comorbidity of hidradenitis suppurativa in Korea for 17 years: A nationwide population‐based cohort study
Hidradenitis suppurativa (HS) is associated with various metabolic and autoimmune diseases. The epidemiology has been analyzed in various studies worldwide. However, epidemiological data on HS for Asian populations are limited. This study aimed to analyze the change in the prevalence and incidence o...
Saved in:
Published in | Journal of dermatology Vol. 50; no. 6; pp. 778 - 786 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
01.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hidradenitis suppurativa (HS) is associated with various metabolic and autoimmune diseases. The epidemiology has been analyzed in various studies worldwide. However, epidemiological data on HS for Asian populations are limited. This study aimed to analyze the change in the prevalence and incidence of HS over 17 years in South Korea using the Korean National Health Insurance Service (NHIS) database. This study also evaluated the comorbidities in patients with HS. Population‐based data from the NHIS database of Korea were obtained between January 2003 and December 2019. Odds ratios were estimated to determine the association between comorbidities and HS during the study period. Hazard ratios for the risk of incident comorbidities in patients with HS were obtained using the multivariable Cox proportional hazard analysis. This study included 45 511 patients with HS and 910 220 controls matched for age, sex, insurance type, and income level. The incidence rate of HS per 1 000 000 person‐years in Korea increased from 11.69 in 2003 to 78.78 in 2019. The annual prevalence per 1 000 000 people also increased from 34.68 in 2003 to 140.10 in 2019, showing a similar trend. Many comorbidities, including atopic, metabolic and end‐organ, autoimmune/inflammatory, and psychiatric diseases were associated with HS at baseline. In many diseases, the risk of incident comorbidities in patients with HS was higher than that in controls. The incidence and prevalence of HS in Korea have increased over the past 17 years. Various comorbidities, including allergic diseases, hypertension, diabetes mellitus, dyslipidemia, myocardial infarction, chronic hepatitis and cirrhosis, chronic kidney disease, inflammatory bowel diseases, rheumatoid arthritis, vitamin D deficiency, and psychiatric diseases, were associated with HS. Physicians need to keep in mind and closely monitor these comorbidities in patients with HS. |
---|---|
AbstractList | Abstract
Hidradenitis suppurativa (HS) is associated with various metabolic and autoimmune diseases. The epidemiology has been analyzed in various studies worldwide. However, epidemiological data on HS for Asian populations are limited. This study aimed to analyze the change in the prevalence and incidence of HS over 17 years in South Korea using the Korean National Health Insurance Service (NHIS) database. This study also evaluated the comorbidities in patients with HS. Population‐based data from the NHIS database of Korea were obtained between January 2003 and December 2019. Odds ratios were estimated to determine the association between comorbidities and HS during the study period. Hazard ratios for the risk of incident comorbidities in patients with HS were obtained using the multivariable Cox proportional hazard analysis. This study included 45 511 patients with HS and 910 220 controls matched for age, sex, insurance type, and income level. The incidence rate of HS per 1 000 000 person‐years in Korea increased from 11.69 in 2003 to 78.78 in 2019. The annual prevalence per 1 000 000 people also increased from 34.68 in 2003 to 140.10 in 2019, showing a similar trend. Many comorbidities, including atopic, metabolic and end‐organ, autoimmune/inflammatory, and psychiatric diseases were associated with HS at baseline. In many diseases, the risk of incident comorbidities in patients with HS was higher than that in controls. The incidence and prevalence of HS in Korea have increased over the past 17 years. Various comorbidities, including allergic diseases, hypertension, diabetes mellitus, dyslipidemia, myocardial infarction, chronic hepatitis and cirrhosis, chronic kidney disease, inflammatory bowel diseases, rheumatoid arthritis, vitamin D deficiency, and psychiatric diseases, were associated with HS. Physicians need to keep in mind and closely monitor these comorbidities in patients with HS. Hidradenitis suppurativa (HS) is associated with various metabolic and autoimmune diseases. The epidemiology has been analyzed in various studies worldwide. However, epidemiological data on HS for Asian populations are limited. This study aimed to analyze the change in the prevalence and incidence of HS over 17 years in South Korea using the Korean National Health Insurance Service (NHIS) database. This study also evaluated the comorbidities in patients with HS. Population‐based data from the NHIS database of Korea were obtained between January 2003 and December 2019. Odds ratios were estimated to determine the association between comorbidities and HS during the study period. Hazard ratios for the risk of incident comorbidities in patients with HS were obtained using the multivariable Cox proportional hazard analysis. This study included 45 511 patients with HS and 910 220 controls matched for age, sex, insurance type, and income level. The incidence rate of HS per 1 000 000 person‐years in Korea increased from 11.69 in 2003 to 78.78 in 2019. The annual prevalence per 1 000 000 people also increased from 34.68 in 2003 to 140.10 in 2019, showing a similar trend. Many comorbidities, including atopic, metabolic and end‐organ, autoimmune/inflammatory, and psychiatric diseases were associated with HS at baseline. In many diseases, the risk of incident comorbidities in patients with HS was higher than that in controls. The incidence and prevalence of HS in Korea have increased over the past 17 years. Various comorbidities, including allergic diseases, hypertension, diabetes mellitus, dyslipidemia, myocardial infarction, chronic hepatitis and cirrhosis, chronic kidney disease, inflammatory bowel diseases, rheumatoid arthritis, vitamin D deficiency, and psychiatric diseases, were associated with HS. Physicians need to keep in mind and closely monitor these comorbidities in patients with HS. |
Author | Heo, Yeon‐Woo Lee, Jong Won Lee, Solam Lee, Ji Hae |
Author_xml | – sequence: 1 givenname: Jong Won orcidid: 0000-0002-2369-8216 surname: Lee fullname: Lee, Jong Won organization: Yonsei University Wonju College of Medicine – sequence: 2 givenname: Yeon‐Woo orcidid: 0000-0003-0444-9377 surname: Heo fullname: Heo, Yeon‐Woo organization: Yonsei University Wonju College of Medicine – sequence: 3 givenname: Ji Hae orcidid: 0000-0002-5132-1627 surname: Lee fullname: Lee, Ji Hae organization: The Catholic University of Korea – sequence: 4 givenname: Solam orcidid: 0000-0001-6458-9449 surname: Lee fullname: Lee, Solam email: solam@yonsei.ac.kr organization: Yonsei University Wonju College of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36806098$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkD1PxSAUQInR6PPp7GYYXarwoIW6GX1-Jy46Ewq3imlLhVbTxbi6-Rv9Jfb51FUWAjn33ORsotXGN4DQDiX7dDwHlPEskZTJfZoJLlbQ5O9nFU0Ik2ky40RsoM0YHwmZ5Skl62iDZZJkJJcT9DpvnYXa-crfD1g3Fhtf-1A467oB-xI_OBu0hcZ1LuLYt20fdOeeNXYNvvIBNC59wFR8vr0PoEM8xEe4GQnfvIxi3Pq2r76fn28fhY6wWPDgQ4dj19thC62Vuoqw_XNP0d3p_Pb4PLm-Obs4PrpODJNcJJprwQ0ruLS54YVJIS8ZYSbPeSlnwCQTQFOeEZNmJQihTWFTwQrGBclMIdkU7S29bfBPPcRO1S4aqCrdgO-jmgkhc8H5KJ2igyVqgo8xQKna4GodBkWJWkRXi8RqkVh9Rx8ndn_kfVGD_eN_K49AugReXAXDfz51eTJfir8A1deRdg |
CitedBy_id | crossref_primary_10_1007_s40257_024_00844_5 crossref_primary_10_34108_eujhs_1306589 crossref_primary_10_3390_nu15173797 |
Cites_doi | 10.1007/s00403-020-02063-4 10.1159/000514582 10.1016/j.jaad.2021.01.059 10.1111/ced.13922 10.1016/j.jaad.2015.07.055 10.1001/jamadermatol.2021.1677 10.1038/jid.2012.162 10.1111/1346-8138.15811 10.7570/jomes20058 10.1111/obr.12229 10.1111/ijd.14313 10.1111/exd.14340 10.1093/rap/rkab108 10.1016/j.jaad.2008.06.020 10.1016/j.jaad.2019.08.090 10.1371/journal.pone.0265672 10.1111/bjd.19435 10.1371/journal.pone.0111593 10.1111/bjd.14268 10.3390/nu11051033 10.1016/j.jaad.2017.08.042 10.1111/ijd.15578 10.1016/j.jaad.2020.12.051 10.1111/bjd.20067 10.1001/jamadermatol.2015.6264 10.1111/1346-8138.15378 10.1016/j.jaad.2017.02.005 10.3349/ymj.2021.62.2.99 10.1111/ijd.14210 10.4082/kjfm.20.0062 10.1001/jamadermatol.2017.0201 10.1111/bjd.16101 10.1007/s13555-018-0264-z 10.1016/j.anai.2021.04.036 10.1111/1346-8138.15038 10.21037/atm-20-1028 10.1038/jid.2012.23 10.1016/S0190-9622(96)90321-7 10.1001/jamadermatol.2019.0891 10.1016/j.jaad.2014.04.001 10.1007/s12026-021-09221-4 10.1111/jdv.15940 10.1111/jdv.16677 10.1016/j.jaad.2021.03.126 10.1159/000481836 10.1111/jdv.17598 10.1080/15384101.2019.1707455 10.7570/jomes.2019.28.1.40 10.1111/jdv.15071 10.1080/09546634.2020.1714538 10.1016/j.prrv.2019.08.002 10.1016/j.jaad.2014.09.012 |
ContentType | Journal Article |
Copyright | 2023 Japanese Dermatological Association. |
Copyright_xml | – notice: 2023 Japanese Dermatological Association. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1111/1346-8138.16747 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1346-8138 |
EndPage | 786 |
ExternalDocumentID | 10_1111_1346_8138_16747 36806098 JDE16747 |
Genre | researchArticle Journal Article |
GrantInformation_xml | – fundername: National Research Foundation of Korea |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 123 1OB 1OC 29K 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AAQQT AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB B.R BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMB EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO ROL RX1 SAMSI SJN SUPJJ SV3 TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 ZZTAW ~IA ~WT NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c3847-a4a74c3b48d9c4bc5e9f303c994f82e3837e15460c56fe77acbd573b34706cb83 |
IEDL.DBID | DR2 |
ISSN | 0385-2407 |
IngestDate | Sat Aug 17 01:09:06 EDT 2024 Fri Aug 23 01:31:54 EDT 2024 Sat Sep 28 08:21:27 EDT 2024 Sat Aug 24 00:53:51 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | epidemiology prevalence hidradenitis suppurativa comorbidity incidence |
Language | English |
License | 2023 Japanese Dermatological Association. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3847-a4a74c3b48d9c4bc5e9f303c994f82e3837e15460c56fe77acbd573b34706cb83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-6458-9449 0000-0002-2369-8216 0000-0002-5132-1627 0000-0003-0444-9377 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1346-8138.16747 |
PMID | 36806098 |
PQID | 2778974430 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2778974430 crossref_primary_10_1111_1346_8138_16747 pubmed_primary_36806098 wiley_primary_10_1111_1346_8138_16747_JDE16747 |
PublicationCentury | 2000 |
PublicationDate | June 2023 2023-Jun 2023-06-00 20230601 |
PublicationDateYYYYMMDD | 2023-06-01 |
PublicationDate_xml | – month: 06 year: 2023 text: June 2023 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of dermatology |
PublicationTitleAlternate | J Dermatol |
PublicationYear | 2023 |
References | 2021; 69 2021; 48 2015; 16 2020; 41 2015; 73 2019; 11 2020; 82 2021; 127 2020; 183 2019; 58 2008; 59 2020; 36 2022; 86 2020; 34 2021; 185 2017; 153 1996; 35 2021; 30 2020; 19 2020; 8 2021; 35 2018; 8 2012; 132 2021; 32 2018; 4 2021; 157 2021; 313 2019; 44 2022; 61 2022; 6 2017; 77 2019; 46 2018; 178 2021; 237 2019; 28 2020; 47 2014; 9 2018; 78 2018; 32 2021; 85 2014; 71 2021; 62 2019; 155 2016; 174 2016; 152 2022; 17 2020; 29 2018; 57 e_1_2_8_28_1 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_3_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_41_1 e_1_2_8_17_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_32_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_53_1 e_1_2_8_51_1 e_1_2_8_30_1 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_40_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_52_1 e_1_2_8_50_1 |
References_xml | – volume: 16 start-page: 1 year: 2015 end-page: 12 article-title: Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies publication-title: Obes Rev – volume: 44 start-page: e126 year: 2019 end-page: 32 article-title: Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta‐analysis publication-title: Clin Exp Dermatol – volume: 185 start-page: 772 year: 2021 end-page: 80 article-title: Inflammatory skin diseases and the risk of chronic kidney disease: population‐based case‐control and cohort analyses publication-title: Br J Dermatol – volume: 155 start-page: 1022 year: 2019 end-page: 7 article-title: Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta‐analysis publication-title: JAMA Dermatol – volume: 132 start-page: 1728 year: 2012 end-page: 30 article-title: Nicastrin mutations in French families with hidradenitis suppurativa publication-title: J Invest Dermatol – volume: 17 year: 2022 article-title: Prevalence of low vitamin D levels in patients with hidradenitis suppurativa in Jordan: a comparative cross‐sectional study publication-title: PLoS One – volume: 4 start-page: 281 year: 2018 end-page: 5 article-title: Hidradenitis suppurativa: an Asian perspective from a Singaporean institute publication-title: Skin Appendage Disord – volume: 313 start-page: 41 year: 2021 end-page: 7 article-title: Age‐specific physical and mental health status in Italian patients with hidradenitis suppurativa: a comparison with the general population publication-title: Arch Dermatol Res – volume: 85 start-page: e387 year: 2021 end-page: 8 article-title: Atopic dermatitis and hidradenitis suppurativa: an under‐recognized pair publication-title: J Am Acad Dermatol – volume: 57 start-page: 1454 year: 2018 end-page: 63 article-title: The clinical, biochemical, and ultrasonographic characteristics of patients with hidradenitis suppurativa in northern peninsular Malaysia: a multicenter study publication-title: Int J Dermatol – volume: 34 start-page: 174 year: 2020 end-page: 9 article-title: Epidemiology of hidradenitis suppurativa in Germany ‐ an observational cohort study based on a multisource approach publication-title: J Eur Acad Dermatol Venereol – volume: 132 start-page: 2459 year: 2012 end-page: 61 article-title: Mutations in the gamma‐secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa) publication-title: J Invest Dermatol – volume: 35 start-page: 191 issue: 2 Pt 1 year: 1996 end-page: 4 article-title: The prevalence of hidradenitis suppurativa and its potential precursor lesions publication-title: J Am Acad Dermatol – volume: 61 start-page: 84 year: 2022 end-page: 8 article-title: Hepatitis B and C among patients with hidradenitis suppurativa: a population‐based study publication-title: Int J Dermatol – volume: 29 start-page: 124 year: 2020 end-page: 32 article-title: Obesity fact sheet in Korea, 2019: prevalence of obesity and abdominal obesity from 2009 to 2018 and social factors publication-title: J Obes Metab Syndr – volume: 178 start-page: 917 year: 2018 end-page: 24 article-title: Population‐based clinical practice research datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa publication-title: Br J Dermatol – volume: 6 start-page: rkab108 year: 2022 article-title: Association of hidradenitis suppurativa with autoimmune disease and autoantibodies publication-title: Rheumatol Adv Pract – volume: 77 start-page: 118 year: 2017 end-page: 22 article-title: Incidence of hidradenitis suppurativa in the United States: a sex‐ and age‐adjusted population analysis publication-title: J Am Acad Dermatol – volume: 127 start-page: 293 year: 2021 end-page: 300 article-title: One march, many paths: insights into allergic march trajectories publication-title: Ann Allergy Asthma Immunol – volume: 73 start-page: S27 issue: 5 Suppl 1 year: 2015 end-page: 35 article-title: Systemic associations of hidradenitis suppurativa publication-title: J Am Acad Dermatol – volume: 174 start-page: 927 year: 2016 end-page: 9 article-title: Phenotype of 53 Chinese individuals with nicastrin gene mutations in association with familial hidradenitis suppurativa (acne inversa) publication-title: Br J Dermatol – volume: 8 start-page: 821 year: 2020 article-title: Hidradenitis suppurativa and psychiatric comorbidities, suicides and substance abuse: systematic review and meta‐analysis publication-title: Ann Transl Med – volume: 46 start-page: 867 year: 2019 end-page: 73 article-title: Increased risk of cardiovascular comorbidities in hidradenitis suppurativa: a nationwide, population‐based, cohort study in Taiwan publication-title: J Dermatol – volume: 183 start-page: 990 year: 2020 end-page: 8 article-title: The epidemiology of hidradenitis suppurativa publication-title: Br J Dermatol – volume: 71 start-page: 1144 year: 2014 end-page: 50 article-title: Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart‐verified case‐control analysis publication-title: J Am Acad Dermatol – volume: 237 start-page: 740 year: 2021 end-page: 7 article-title: Association between hidradenitis suppurativa and inflammatory arthritis: a systematic review and meta‐analysis publication-title: Dermatology – volume: 59 start-page: 596 year: 2008 end-page: 601 article-title: Prevalence and factors associated with hidradenitis suppurativa: results from two case‐control studies publication-title: J Am Acad Dermatol – volume: 30 start-page: 23 issue: Suppl 1 year: 2021 end-page: 6 article-title: Hidradenitis suppurativa in South‐East Asia and East Asia publication-title: Exp Dermatol – volume: 47 start-page: 743 year: 2020 end-page: 8 article-title: Questionnaire‐based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries publication-title: J Dermatol – volume: 48 start-page: 613 year: 2021 end-page: 9 article-title: Epidemiology of hidradenitis suppurativa in Taiwan: a 14‐year nationwide population‐based study publication-title: J Dermatol – volume: 28 start-page: 40 year: 2019 end-page: 5 article-title: Korean Society for the Study of Obesity (KSSO) 2018 Korean Society for the Study of Obesity guideline for the management of obesity in Korea publication-title: J Obes Metab Syndr – volume: 157 start-page: 924 year: 2021 end-page: 31 article-title: Prevalence of hidradenitis suppurativa: a systematic review and meta‐regression analysis publication-title: JAMA Dermatol – volume: 58 start-page: e57 year: 2019 end-page: 8 article-title: Rethinking the female predominance in hidradenitis suppurativa publication-title: Int J Dermatol – volume: 19 start-page: 257 year: 2020 end-page: 67 article-title: Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo publication-title: Cell Cycle – volume: 152 start-page: 429 year: 2016 end-page: 34 article-title: Risk of major adverse cardiovascular events and all‐cause mortality in patients with hidradenitis suppurativa publication-title: JAMA Dermatol – volume: 9 year: 2014 article-title: Dietary patterns of Korean adults and the prevalence of metabolic syndrome: a cross‐sectional study publication-title: PLoS One – volume: 82 start-page: 1045 year: 2020 end-page: 58 article-title: Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis publication-title: J Am Acad Dermatol – volume: 8 start-page: 557 year: 2018 end-page: 69 article-title: The comorbidity burden of hidradenitis suppurativa in the United States: a claims data analysis publication-title: Dermatol Ther (Heidelb) – volume: 41 start-page: 146 year: 2020 end-page: 52 article-title: Conducting and reporting a clinical research using Korean healthcare claims database publication-title: Korean J Fam Med – volume: 35 start-page: 2431 year: 2021 end-page: 9 article-title: Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study publication-title: J Eur Acad Dermatol Venereol – volume: 32 start-page: 843 year: 2021 end-page: 4 article-title: Vitamin D deficiency and hidradenitis suppurativa: the impact on clinical severity and therapeutic responsivity publication-title: J Dermatolog Treat – volume: 32 start-page: 1784 year: 2018 end-page: 90 article-title: Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population‐based study publication-title: J Eur Acad Dermatol Venereol – volume: 86 start-page: 1092 year: 2022 end-page: 101 article-title: Comorbidity screening in hidradenitis suppurativa: evidence‐based recommendations from the US and Canadian hidradenitis suppurativa foundations publication-title: J Am Acad Dermatol – volume: 78 start-page: 395 year: 2018 end-page: 402 article-title: Hidradenitis suppurativa and diabetes mellitus: a systematic review and meta‐analysis publication-title: J Am Acad Dermatol – volume: 11 start-page: 1033 year: 2019 article-title: Implications of the westernized diet in the onset and progression of IBD publication-title: Nutrients – volume: 153 start-page: 760 year: 2017 end-page: 4 article-title: Sex‐ and age‐adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States publication-title: JAMA Dermatol – volume: 85 start-page: 1473 year: 2021 end-page: 9 article-title: Hidradenitis suppurativa and atopic dermatitis: a 2‐way association publication-title: J Am Acad Dermatol – volume: 35 start-page: 50 year: 2021 end-page: 61 article-title: Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life publication-title: J Eur Acad Dermatol Venereol – volume: 36 start-page: 118 year: 2020 end-page: 27 article-title: Understanding the immunology of asthma: pathophysiology, biomarkers, and treatments for asthma endotypes publication-title: Paediatr Respir Rev – volume: 69 start-page: 533 year: 2021 end-page: 40 article-title: Hidradenitis suppurativa and rheumatoid arthritis: evaluating the bidirectional association publication-title: Immunol Res – volume: 71 start-page: 460 year: 2014 end-page: 7 article-title: Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity publication-title: J Am Acad Dermatol – volume: 62 start-page: 99 year: 2021 end-page: 108 article-title: Incidence and prevalence of inflammatory bowel disease across Asia publication-title: Yonsei Med J – ident: e_1_2_8_4_1 doi: 10.1007/s00403-020-02063-4 – ident: e_1_2_8_47_1 doi: 10.1159/000514582 – ident: e_1_2_8_6_1 doi: 10.1016/j.jaad.2021.01.059 – ident: e_1_2_8_38_1 doi: 10.1111/ced.13922 – ident: e_1_2_8_7_1 doi: 10.1016/j.jaad.2015.07.055 – ident: e_1_2_8_20_1 doi: 10.1001/jamadermatol.2021.1677 – ident: e_1_2_8_30_1 doi: 10.1038/jid.2012.162 – ident: e_1_2_8_13_1 doi: 10.1111/1346-8138.15811 – ident: e_1_2_8_16_1 doi: 10.7570/jomes20058 – ident: e_1_2_8_37_1 doi: 10.1111/obr.12229 – ident: e_1_2_8_22_1 doi: 10.1111/ijd.14313 – ident: e_1_2_8_25_1 doi: 10.1111/exd.14340 – ident: e_1_2_8_48_1 doi: 10.1093/rap/rkab108 – ident: e_1_2_8_24_1 doi: 10.1016/j.jaad.2008.06.020 – ident: e_1_2_8_2_1 doi: 10.1016/j.jaad.2019.08.090 – ident: e_1_2_8_51_1 doi: 10.1371/journal.pone.0265672 – ident: e_1_2_8_3_1 doi: 10.1111/bjd.19435 – ident: e_1_2_8_36_1 doi: 10.1371/journal.pone.0111593 – ident: e_1_2_8_29_1 doi: 10.1111/bjd.14268 – ident: e_1_2_8_19_1 doi: 10.3390/nu11051033 – ident: e_1_2_8_39_1 doi: 10.1016/j.jaad.2017.08.042 – ident: e_1_2_8_49_1 doi: 10.1111/ijd.15578 – ident: e_1_2_8_17_1 doi: 10.1016/j.jaad.2020.12.051 – ident: e_1_2_8_50_1 doi: 10.1111/bjd.20067 – ident: e_1_2_8_43_1 doi: 10.1001/jamadermatol.2015.6264 – ident: e_1_2_8_26_1 doi: 10.1111/1346-8138.15378 – ident: e_1_2_8_10_1 doi: 10.1016/j.jaad.2017.02.005 – ident: e_1_2_8_44_1 doi: 10.3349/ymj.2021.62.2.99 – ident: e_1_2_8_28_1 doi: 10.1111/ijd.14210 – ident: e_1_2_8_14_1 doi: 10.4082/kjfm.20.0062 – ident: e_1_2_8_21_1 doi: 10.1001/jamadermatol.2017.0201 – ident: e_1_2_8_11_1 doi: 10.1111/bjd.16101 – ident: e_1_2_8_41_1 doi: 10.1007/s13555-018-0264-z – ident: e_1_2_8_35_1 doi: 10.1016/j.anai.2021.04.036 – ident: e_1_2_8_40_1 doi: 10.1111/1346-8138.15038 – ident: e_1_2_8_53_1 doi: 10.21037/atm-20-1028 – ident: e_1_2_8_31_1 doi: 10.1038/jid.2012.23 – ident: e_1_2_8_9_1 doi: 10.1016/S0190-9622(96)90321-7 – ident: e_1_2_8_45_1 doi: 10.1001/jamadermatol.2019.0891 – ident: e_1_2_8_23_1 doi: 10.1016/j.jaad.2014.04.001 – ident: e_1_2_8_46_1 doi: 10.1007/s12026-021-09221-4 – ident: e_1_2_8_8_1 doi: 10.1111/jdv.15940 – ident: e_1_2_8_5_1 doi: 10.1111/jdv.16677 – ident: e_1_2_8_18_1 doi: 10.1016/j.jaad.2021.03.126 – ident: e_1_2_8_27_1 doi: 10.1159/000481836 – ident: e_1_2_8_32_1 doi: 10.1111/jdv.17598 – ident: e_1_2_8_33_1 doi: 10.1080/15384101.2019.1707455 – ident: e_1_2_8_15_1 doi: 10.7570/jomes.2019.28.1.40 – ident: e_1_2_8_12_1 doi: 10.1111/jdv.15071 – ident: e_1_2_8_52_1 doi: 10.1080/09546634.2020.1714538 – ident: e_1_2_8_34_1 doi: 10.1016/j.prrv.2019.08.002 – ident: e_1_2_8_42_1 doi: 10.1016/j.jaad.2014.09.012 |
SSID | ssj0029510 |
Score | 2.4032915 |
Snippet | Hidradenitis suppurativa (HS) is associated with various metabolic and autoimmune diseases. The epidemiology has been analyzed in various studies worldwide.... Abstract Hidradenitis suppurativa (HS) is associated with various metabolic and autoimmune diseases. The epidemiology has been analyzed in various studies... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 778 |
SubjectTerms | comorbidity epidemiology hidradenitis suppurativa incidence prevalence |
Title | Epidemiology and comorbidity of hidradenitis suppurativa in Korea for 17 years: A nationwide population‐based cohort study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1346-8138.16747 https://www.ncbi.nlm.nih.gov/pubmed/36806098 https://search.proquest.com/docview/2778974430 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT-MwELYQB8SF5blbXjLSHrikSmrHdrhVUFSB4LACiVtkO46oVkqqthEqB8SVG7-RX8KM05TXAa32lovHiWfG8008_oaQ31wBSNUyD5zUkKBE2gWQq4hAI1ldJ9KJ077a4lL0r_nZTdxUE-JdmJofYv7DDT3D79fo4NqM3zl5xLgIVMRUGwvp8T450ukhLPozJ5DqIH7w5wgqxnMEOSP3wVqeT-M_xqUvYPMjdvXB5_QHMc1r1zUnf9vVxLTt_SdGx__6rlWyMoOmtFvb0hpZcMU6WbqYHb5vkIfeWzfZKdVFRkF0OTKDDJA8LXN6O8hGGvYxpEmi42o4rDytuKaDgp6XgE4pIGQayZfHpyk42PiIdmn9M_IOBNPhvJfYy-MzRlec4BbSA-o5cDfJ9Wnv6rgfzNo3BJZBzAs02AC3zHCVJZYbG7skh4Bpk4TnquMwNXYA4ERoY5E7KbU1WSyZYVyGwhrFtshiURbuF6HGQpZqdS4ya7gDpK0ThCYgXkK6qfIWOWyUlw5rlo60yW5wPVNcz9SvZ4scNMpNwZPweEQXrqzGaUdKNFzOwhb5WWt9LowJFYowUS1S6-67WdKzk55_2P7XATtkGTva19Vou2RxMqrcHuCeidn3pv0KWQn5Uw |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07b9swED60KdBmSd-J07RlgQ5dZEgmRVLZgsSBm9dQJEA2gaQoxCggGbaFIB2KrNnyG_NLckfZzqNDUXTToqPEu9N9xzt9B_BVaASpRpWRVwYTlMT4CHMVGRkiq-slJvMmdFscycGJ2DtNT-_9C9PyQywO3MgzwveaHJwOpO95ecKFjHTCdZc66dVTeIZOn4a06seCQqpHCCJUEnRKlQQ1o_ehbp5HAh5Gpj_g5kP0GsLP7ktw8wdvu05-dpup7bpfjzgd_-_NXsHKDJ2yrdacXsMTX72B54ez-vtb-N2_Gyh7wUxVMJRdj-2wQDDP6pKdDYuxwU8ZMSWxSTMaNYFZ3LBhxfZrBKgMQTJL1M3l1QX62GSTbbH2PPIcBbPRYpzYzeU1BVha4AwzBBZocN_ByW7_eHsQzSY4RI5j2IsMmoFw3ApdZE5Yl_qsxJjpskyUuucpO_aI4WTsUll6pYyzRaq45ULF0lnN38NSVVd-DZh1mKg6U8rCWeERbJuM0AmKV5hx6rID3-bay0ctUUc-T3BoP3PazzzsZwe-zLWbozNRhcRUvm4meU8psl3B4w6stmpfCONSxzLOdAda5f1tlXxvpx8u1v_1hs_wYnB8eJAffD_a_wDLNOC-bU7bgKXpuPEfEQZN7adg57cGC_11 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BkSou5V2Wp5E4cMkqiR3b4VaxuyotVAhRiVtkO466Qkqi3Y2qckC9cuM39pcw42wWWg4Iccsl48Qz4_kmM_kG4KXQCFKNqiKvDCYoifER5ioyMkRWlyYm9yZ0WxzJ_WNx8DkbugnpX5ieH2LzwY08I5zX5OBtWf3m5AkXMtIJ12NqpFfX4YaQPCXDnnzcMEilBCBCIUFnVEhQa3Yfaua5IuByYPoDbV4GryH6zG6BHZ67bzr5Mu5Wduy-XqF0_K8Xuw07a2zK9npjugPXfH0Xtt-vq-_34Nv01zjZM2bqkqHoZmHnJUJ51lTsZF4uDB5kxJPEll3bdoFX3LB5zQ4bhKcMITJL1MX59zP0sOVrtsf6r5GnKJi1m2FiF-c_KLzSAieYH7BAgnsfjmfTT2_2o_X8hshxDHqRQSMQjluhy9wJ6zKfVxgxXZ6LSqeecmOPCE7GLpOVV8o4W2aKWy5ULJ3V_AFs1U3tHwKzDtNUZypZOis8Qm2TEzZB8QrzTV2N4NWgvKLtaTqKIb2h_SxoP4uwnyN4MSi3QFei-oipfdMti1QpslzB4xHs9lrfCONSxzLO9Qh63f1tleJgMg0Xj_71huew_WEyK969PTp8DDdpun3fmfYEtlaLzj9FDLSyz4KV_wQM6fwk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+and+comorbidity+of+hidradenitis+suppurativa+in+Korea+for+17%E2%80%89years%3A+A+nationwide+population%E2%80%90based+cohort+study&rft.jtitle=Journal+of+dermatology&rft.au=Lee%2C+Jong+Won&rft.au=Heo%2C+Yeon%E2%80%90Woo&rft.au=Lee%2C+Ji+Hae&rft.au=Lee%2C+Solam&rft.date=2023-06-01&rft.issn=0385-2407&rft.eissn=1346-8138&rft.volume=50&rft.issue=6&rft.spage=778&rft.epage=786&rft_id=info:doi/10.1111%2F1346-8138.16747&rft.externalDBID=10.1111%252F1346-8138.16747&rft.externalDocID=JDE16747 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-2407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-2407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-2407&client=summon |